CN106581497A - Traditional Chinese medicinal composition for treating diabetes - Google Patents
Traditional Chinese medicinal composition for treating diabetes Download PDFInfo
- Publication number
- CN106581497A CN106581497A CN201710063797.3A CN201710063797A CN106581497A CN 106581497 A CN106581497 A CN 106581497A CN 201710063797 A CN201710063797 A CN 201710063797A CN 106581497 A CN106581497 A CN 106581497A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicinal
- treating diabetes
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of medicines for treating diabetes, and especially relates to a traditional Chinese medicinal composition for treating diabetes. The traditional Chinese medicinal composition comprises, by weight, 30-35 parts of Chinese yam, 50-60 parts of balsam pear, 20-30 parts of reed rhizome, 30-40 parts of aloe, 20-30 parts of dendrobium, 30-40 parts of towel gourd, 50-60 parts of watermelon peel and 20-30 parts of Sowthistleleaf Tasselflower. The composition is based on the traditional Chinese medicinal principle of treatment of both symptoms and root causes, and clinic test shows that the composition has the efficacy of tonifying qi and nourishing yin, and generating body fluid and clearing heat, effectively reduces the blood sugar, and fast recovers the energy and the muscle power of patients after being taken.
Description
Technical field
The present invention relates to treat diabetes medicament technical field, the Chinese medicine composition of diabetes is specifically treated.
Background technology
The western medicine method of diabetes is control blood glucose, reduces the lifelong medication of complication.Clinically due to diabetes
Lifelong dependency and recurrent exerbation to medicine so that diabetes become " incurable disease ", even if patient is dropping in a certain stage
Blood glucose is very steady under the intervention of sugared medicine administered by injection, but as long as be discontinued having a rebound soon, and becomes three big killers of human health
One of.
Diabetes are one of big difficult and complicated illness in the world three, and in decades, countries in the world have carried out one after another long-term and unremitting grinding
Study carefully and exploitation.There is important breakthrough twice in treatment diabetes history：It it is for the first time the 1950's, first Chinese is artificial
Insulin synthesis, make a stir all over the world；It is for the second time the appearance of biguanideses and sulphanylureas oral antidiabetic drug, makes the blood glucose of diabeticss
Temporarily controlled.Tens of kinds have been reached currently used for Chinese medicine and western medicine used by clinical treatment, but due to grinding to diabetes pathology, the cause of disease
Study carefully so far also without substantial breakthrough, treatment diabetes increase the stage still in control blood glucose, glucose in urine and prevention is comprehensive concurrent
The conceptual phase of disease.Additionally, the internal organs such as kidney, liver, the heart, spleen, stomach can be brought side effect by patient's long-term taking Western medicine.It is domestic new
Various pure Chinese medicinal preparations its drug effect for developing also is in controlling blood glucose, glucose in urine increasing the stage, without any one medicine
There is repair to human pancreas tissue injury and obtain convictive scientific basis.
The content of the invention
It is an object of the invention to overcome the deficiencies in the prior art, there is provided a kind of Chinese medicine for safely and effectively treating diabetes
Compositionss.
To achieve these goals, technical scheme is as follows：A kind of Chinese medicine composition for treating diabetes, the group
Compound includes following component,
Used as improvement, preferred compositionss component is：
The present invention is mainly formed based on the principle of traditional Chinese medical science treating both the principal and secondary aspects of a disease by Medicine Food Homology drug matching, is had no side effect, energy
Effectively release or reduce the side effect of existing diabetes Western medicine.Jing clinical trials, the formula has supplementing QI and nourishing YIN, replenishing body fluid and clearing away heat pathogen
Effect, can effectively reduce blood glucose, and clothes for patients energy, muscle power after the formula etc. recover also very fast.
Specific embodiment
Embodiment 1
A kind of Chinese medicine composition for treating diabetes, said composition includes following component,
Effect explanation：55 experimenters are divided into into two groups, one group of 28 people takes this formula, another group of 27 people take Ge Lieben
Urea.The course for the treatment of is 12 weeks.Two groups of clinical efficacies are observed, deficiency of both QI and YIN symptom improves blood glucose (FPG, 2hPG) before and after situation and treatment
Situation of change, and be analyzed.
As a result：The 1st day detection fasting glucose FPG level of one group of 28 type 2 diabetes mellitus patient for taking this formula is 17.85
± 9.67mmol/L, 2hPG are 27.12 ± 12.22mmol/L.It is respectively within the 12nd week after taking：FPG levels be 6.85 ±
2.92mmol/L, 2hPG are 9.87 ± 6.98mmol/L.Index is illustrated, with being obviously improved, the function such as energy, muscle power of patient
Recovery it is also very fast.
Jing Statistical Comparisons, take this formula one group, total effective rate is 91.6%, and take Glibenclamide one group is always effective
Rate is 86.1%, and there was no significant difference (P ＞ 0.05) for two groups of curative effects.Deficiency of both QI and YIN symptom has different degrees of after two groups of treatments
Improve, take one group of deficiency of both QI and YIN symptom improvement rate of this formula apparently higher than taking one group of Glibenclamide.After two groups of treatments
Blood glucose (FPG, 2hPG) is improved, but two groups of blood glucose (FPG, 2hPG) after the treatment, the HbAIc (P that compares that there was no significant difference
＞ 0.05).And tri- indexs of Fins, HOMA-IS, HOMA-IR, take one group of this formula and compare and take the one of Glibenclamide
Group, with being obviously improved (P ＜ 0.05).
Embodiment 2
A kind of Chinese medicine composition for treating diabetes, said composition includes following component,
Certain patient, suffers from diabetes 15 years, and before taking this formula, fasting blood sugar is 25.3mmol/L.In early daily,
Evening each oral this formula is once.After 15 days, the energy of patient, muscle power have substantially recovery, and fasting blood sugar is 11.5mmol/L.Even
After taking 60 days, fasting blood sugar is 6.1mmol/L.Now up to 11 months, fasting glucose value stabilization exists this formula of the clothes for patients
For between 4.1～5.3mmol/L.
Claims (2)
1. a kind of Chinese medicine composition for treating diabetes, it is characterised in that：Said composition includes following component,
2. the Chinese medicine composition of diabetes is treated as claimed in claim 1, it is characterised in that：Said composition is included such as the following group
Point,
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710063797.3A CN106581497A (en) | 2017-01-19 | 2017-01-19 | Traditional Chinese medicinal composition for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710063797.3A CN106581497A (en) | 2017-01-19 | 2017-01-19 | Traditional Chinese medicinal composition for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106581497A true CN106581497A (en) | 2017-04-26 |
Family
ID=58586685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710063797.3A Pending CN106581497A (en) | 2017-01-19 | 2017-01-19 | Traditional Chinese medicinal composition for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106581497A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705696A (en) * | 2013-12-27 | 2014-04-09 | 河南九福来科技集团股份有限公司 | Method for preparing powder injection for treating diabetes by using aloes and Chinese yam |
-
2017
- 2017-01-19 CN CN201710063797.3A patent/CN106581497A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705696A (en) * | 2013-12-27 | 2014-04-09 | 河南九福来科技集团股份有限公司 | Method for preparing powder injection for treating diabetes by using aloes and Chinese yam |
Non-Patent Citations (4)
| Title |
|---|
| 尹继全: "芦荟苦瓜榨取液治疗早期糖尿病肾病的临床观察", 《中国医药指南》 * |
| 张清: "《慢性病饮食+运动+中医调养全书》", 30 June 2016 * |
| 景金霞等: "应用浊毒理论对消渴患者的辨证护理", 《河北中医》 * |
| 田培燕: "一点红对 STZ 诱导糖尿病大鼠的降血糖作用及机制研究", 《中药材》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100374138C (en) | Traditional Chinese medicine composition for treating kidney-yang deficiency and deficiency of vital energy and blood, its prepn. process | |
| CN1342462A (en) | Composite medicine for treating rheumatoid arthritis | |
| CN101690789B (en) | Chinese medicinal preparation for treating diabetes | |
| CN104043045B (en) | Treat the pharmaceutical composition of optic atrophy | |
| CN106581497A (en) | Traditional Chinese medicinal composition for treating diabetes | |
| CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
| CN101549138B (en) | Acne treating Chinese medicine preparation and method of producing the same | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN102988564A (en) | Traditional Chinese medicine composition for treating solar dermatitis | |
| CN105343419A (en) | Traditional Chinese medicinal pill for invigorating yang and tonifying kidney, and preparation method thereof | |
| CN101549074B (en) | Drug for treating hyperplasia of mammary glands | |
| CN1181249A (en) | Infantile diarrhea paste | |
| CN104524411B (en) | A kind of compound preparation for being used to treat chronic liver disease hypoalbuminemia | |
| CN109395045A (en) | A kind of clearing away heat and eliminating dampeness tune sugar-pill and preparation method thereof for treating diabetes B MIDDLE ENERGIZER DAMPNESS-HEAT | |
| CN108743885A (en) | A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications | |
| CN102423414B (en) | External Chinese medicinal preparation for treating cold-accumulation and qi-stagnation stomachache | |
| CN106309921A (en) | Capsule medicine for treating liver-kidney yin deficiency and yin blood deficiency and preparation method thereof | |
| CN101485845A (en) | Chinese medicine for treating diabetes | |
| CN107375685A (en) | A kind of Chinese medicine composition for treating decrease of platelet | |
| CN104606578A (en) | Traditional Chinese medicine composition for treating superficial thrombophebitis caused by medicine | |
| CN111558020A (en) | Medicine for treating liver cirrhosis | |
| CN104524313A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome | |
| CN102416112B (en) | Chinese medicinal composition for treating diabetes | |
| CN115400175A (en) | Traditional Chinese medicine composition for treating chronic renal failure | |
| CN103877500A (en) | Medicinal liquor for treating diseases caused by wind-cold-wetness evil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170426 |